Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 4/20 | 0.63 |
| ▸ | GNPAT | O15228 | 1/20 | 0.60 |
| ▸ | ALPI | P09923 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.59 |
| ▸ | XIAP | P98170 | 1/20 | 0.59 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.59 |
| ▸ | CTSC | P53634 | 1/20 | 0.58 |
| ▸ | ACE | P12821 | 3/20 | 0.57 |
| ▸ | CPA1 | P15085 | 3/20 | 0.57 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30164562 | 1.00 | MME (0.63) | MMEGNPATALPIPKMPTGS1 | |
| SCHEMBL30862442 | 1.00 | MME (0.63) | MMEGNPATALPIPKMPTGS1 | |
| SCHEMBL30862444 | 1.00 | MME (0.63) | MMEGNPATALPIPKMPTGS1 | |
| SCHEMBL30862462 | 1.00 | MME (0.63) | MMEGNPATALPIPKMPTGS1 | |
| SCHEMBL30862446 | 1.00 | MME (0.63) | MMEGNPATALPIPKMPTGS1 | |
| SCHEMBL14772130 | 1.00 | MME (0.63) | MMEGNPATALPIPKMPTGS1 | |
| SCHEMBL8082487 | 1.00 | MME (0.63) | MMEGNPATALPIPKMPTGS1 | |
| SCHEMBL30862459 | 1.00 | MME (0.63) | MMEGNPATALPIPKMPTGS1 | |
| SCHEMBL30862466 | 1.00 | MME (0.63) | MMEGNPATALPIPKMPTGS1 | |
| SCHEMBL8082492 | 1.00 | MME (0.63) | MMEGNPATALPIPKMPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11952433-B2 | Heterochiral peptide-complex and composition for measuring nuclear magnetic resonance spectroscopy residual dipolar coupling containing self-assembled intermediates of heterochiral peptide-complex | INDUSTRY ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2024-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11952433-B2 | Heterochiral peptide-complex and composition for measuring nuclear magnetic resonance spectroscopy residual dipolar coupling containing self-assembled intermediates of heterochiral peptide-complex | HM13, PRRC2C, IAPP | MME 862/4885GNPAT 2655/4885ALPI 3996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.